Removal of immunoglobulins by a protein A versus an antihuman immunoglobulin G-based system:: Evaluation of 602 sessions of extracorporeal immunoadsorption

被引:30
作者
Matic, G
Hofmann, D
Winkler, R
Tiess, M
Michelsen, A
Schneidewind, JM
Hebestreit, G
Keysser, M
Müller, W
Kinze, EM
Ramlow, W
机构
[1] Dialysegemeinschaft Nord eV, D-18059 Rostock, Germany
[2] Klinikum Sudstadt, Rostock, Germany
[3] Labor Muller, Rostock, Germany
[4] Muritz Klin, Klink, Germany
关键词
plasma exchange; plasmapheresis; therapeutic apheresis; immunoadsorption;
D O I
10.1046/j.1525-1594.2000.06490.x
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Elimination of IgG can be achieved by extracorporeal immunoadsorption (IA) based on specific binding to either staphylococcal protein A (Excorim) or sheep polyclonal antibodies directed against human IgG (Therasorb). In 602 analyzed sessions of IA, elimination of IgG was 60% through 80% depending on the treated plasma volume, with no significant difference between the mentioned systems. However, the decrease of IgM and IgA was approximately 50% in the anti-IgG compared to 20-40% in the protein A system. Plasma albumin concentration decreased by 20% in the anti-IgG system compared to 15% in the protein A system, and hemoglobin values increased by 2% in the anti-IgG system and decreased by 6% in the protein A system. In conclusion, a clinical relevance for these findings cannot be ruled out, and the individual choice might depend on the clinical situation and laboratory findings.
引用
收藏
页码:103 / 107
页数:5
相关论文
共 14 条
[1]   Immune modulation associated with extracorporeal immunoadsorption treatments utilizing protein A silica columns [J].
Balint, JP .
ARTIFICIAL ORGANS, 1996, 20 (08) :906-913
[2]   Treatment of severe hyperlipidemia: Six years' experience with low-density lipoprotein apheresis [J].
Bambauer, R ;
Schiel, R ;
Latza, R ;
Klinkmann, J .
ARTIFICIAL ORGANS, 1996, 20 (04) :336-339
[3]   Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy [J].
Dorffel, WV ;
Felix, SB ;
Wallukat, G ;
Brehme, S ;
Bestvater, K ;
Hofmann, T ;
Kleber, FX ;
Baumann, G ;
Reinke, P .
CIRCULATION, 1997, 95 (08) :1994-1997
[4]  
GJORSTRUP P, 1991, VOX SANG, V61, P244
[5]   Prevention of hyperacute rejection by removal of antibodies to HLA immediately before renal transplantation [J].
Higgins, RM ;
Bevan, DJ ;
Carey, BS ;
Lea, CK ;
Fallon, M ;
Buhler, R ;
Vaughan, RW ;
ODonnell, PJ ;
Snowden, SA ;
Bewick, M ;
Hendry, BM .
LANCET, 1996, 348 (9036) :1208-1211
[6]   ADSORPTION PROFILE OF COMMERCIALLY AVAILABLE ADSORBENTS - AN INVITRO EVALUATION [J].
IKONOMOV, V ;
SAMTLEBEN, W ;
SCHMIDT, B ;
BLUMENSTEIN, M ;
GURLAND, HJ .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1992, 15 (05) :312-319
[7]  
KNOBL P, 1995, THROMB HAEMOSTASIS, V74, P1035
[8]   The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants [J].
Lin, SS ;
Weidner, BC ;
Byrne, GW ;
Diamond, LE ;
Lawson, JH ;
Hoopes, CW ;
Daniels, LJ ;
Daggett, CW ;
Parker, W ;
Harland, RC ;
Davis, RD ;
Bollinger, RR ;
Logan, JS ;
Platt, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) :1745-1756
[9]   THE INTERACTION BETWEEN DIFFERENT DOMAINS OF STAPHYLOCOCCAL PROTEIN-A AND HUMAN POLYCLONAL IGG, IGA, IGM AND F(AB')2 - SEPARATION OF AFFINITY FROM SPECIFICITY [J].
LJUNGBERG, UK ;
JANSSON, B ;
NISS, U ;
NILSSON, R ;
SANDBERG, BEB ;
NILSSON, B .
MOLECULAR IMMUNOLOGY, 1993, 30 (14) :1279-1285
[10]  
PALMER A, 1989, LANCET, V1, P10